Comparison of two Treatment modalities in external genital warts
Phase 3
- Conditions
- Health Condition 1: A630- Anogenital (venereal) warts
- Registration Number
- CTRI/2024/05/067393
- Lead Sponsor
- GMC Amritsar Punjab
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed cases for atleast 3 months duration
Give informed consent
Exclusion Criteria
patients having unrealistic expectations or having psychiatric illness
patients with renal, cardiac or hepatic disorders
immunocompromised patients
Pregnancy and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of cases with complete clearance <br/ ><br>Time taken for complete clearance <br/ ><br>Mean change in number of lesions <br/ ><br>recurrences <br/ ><br>adverse events <br/ ><br>Timepoint: at baseline at 4 weeks at 8 weeks, 12 weeks and 16 weeks with a follow up period of 3 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Treatment sessions required for complete clearance of genital warts. <br/ ><br>Time taken for complete clearance of genital warts. <br/ ><br>Mean change from the baseline <br/ ><br>recurrences and <br/ ><br>adverse effects <br/ ><br>Timepoint: 20 weeks <br/ ><br> 24 weeks <br/ ><br> 28 weeks <br/ ><br> 32 weeks post treatment follow up period